9 studies found for:    Peutz-Jeghers Syndrome
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
Conditions: Peutz-Jeghers Syndrome;   Neoplastic Processes;   Neoplasm Metastasis
Intervention: Drug: Everolimus
2 Terminated
Has Results
Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
Condition: Peutz-Jeghers Syndrome
Intervention: Drug: Everolimus
3 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
4 Completed Cancer of the Pancreas Screening Study (CAPS 3)
Conditions: Pancreatic Neoplasm;   Peutz-Jeghers Syndrome
Interventions: Procedure: Biopsy, Fine Needle Aspiration (FNA);   Drug: Secretin (human synthetic) - ChiRhoClin
5 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
6 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
Intervention:
7 Active, not recruiting Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)
Conditions: Primary; Complex;   Pigmented Nodular Adrenocortical Disease, Primary, 1;   Periorificial Lentiginosis;   Cardiac Myxoma
Intervention:
8 Terminated
Has Results
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Intervention: Drug: Synthetic Human Secretin
9 Recruiting Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Familial Ovarian Cancer;   Familial Breast Cancer;   BRCA1-associate Malignancies;   BRCA2-associated Malignancies
Intervention:

Indicates status has not been verified in more than two years